Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation

Fabrizio De Benedetti, Tonino Alonzi, Antonia Moretta, Domenico Lazzaro, Patrizia Costa, Valeria Poli, Alberto Martini, Gennaro Ciliberto, Elena Fattori

Research output: Contribution to journalArticle

390 Citations (Scopus)

Abstract

Stunted growth is a major complication of chronic inflammation and recurrent infections in children. Systemic juvenile rheumatoid arthritis is a chronic inflammatory disorder characterized by markedly elevated circulating levels of IL-6 and stunted growth. In this study we found that NSE/hIL-6 transgenic mouse lines expressing high levels of circulating IL-6 since early after birth presented a reduced growth rate that led to mice 50- 70% the size of nontransgenic littermates. Administration of a monoclonal antibody to the murine IL-6 receptor partially reverted the growth defect. In NSE/hIL-6 transgenic mice, circulating IGF-I levels were significantly lower than those of nontransgenic littermates; on the contrary, the distribution of growth hormone pituitary cells, as well as circulating growth hormone levels, were normal. Treatment of nontransgenic mice of the same strain with IL-6 resulted in a significant decrease in IGF-I levels. Moreover, in patients with systemic juvenile rheumatoid arthritis, circulating IL-6 levels were negatively correlated with IGF-I levels. Our findings suggest that IL-6-mediated decrease in IGF-I production represents a major mechanism by which chronic inflammation affects growth.

Original languageEnglish
Pages (from-to)643-650
Number of pages8
JournalJournal of Clinical Investigation
Volume99
Issue number4
Publication statusPublished - Feb 15 1997

Fingerprint

Growth Disorders
Insulin-Like Growth Factor I
Transgenic Mice
Interleukin-6
Inflammation
Growth
Growth Hormone
Interleukin-6 Receptors
Monoclonal Antibodies
Parturition
Infection

Keywords

  • growth disorders
  • insulin-like growth factor-I
  • interleukin 6
  • juvenile rheumatoid arthritis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{70c9234be566416289ce0af4a49b278b,
title = "Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation",
abstract = "Stunted growth is a major complication of chronic inflammation and recurrent infections in children. Systemic juvenile rheumatoid arthritis is a chronic inflammatory disorder characterized by markedly elevated circulating levels of IL-6 and stunted growth. In this study we found that NSE/hIL-6 transgenic mouse lines expressing high levels of circulating IL-6 since early after birth presented a reduced growth rate that led to mice 50- 70{\%} the size of nontransgenic littermates. Administration of a monoclonal antibody to the murine IL-6 receptor partially reverted the growth defect. In NSE/hIL-6 transgenic mice, circulating IGF-I levels were significantly lower than those of nontransgenic littermates; on the contrary, the distribution of growth hormone pituitary cells, as well as circulating growth hormone levels, were normal. Treatment of nontransgenic mice of the same strain with IL-6 resulted in a significant decrease in IGF-I levels. Moreover, in patients with systemic juvenile rheumatoid arthritis, circulating IL-6 levels were negatively correlated with IGF-I levels. Our findings suggest that IL-6-mediated decrease in IGF-I production represents a major mechanism by which chronic inflammation affects growth.",
keywords = "growth disorders, insulin-like growth factor-I, interleukin 6, juvenile rheumatoid arthritis",
author = "{De Benedetti}, Fabrizio and Tonino Alonzi and Antonia Moretta and Domenico Lazzaro and Patrizia Costa and Valeria Poli and Alberto Martini and Gennaro Ciliberto and Elena Fattori",
year = "1997",
month = "2",
day = "15",
language = "English",
volume = "99",
pages = "643--650",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "4",

}

TY - JOUR

T1 - Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation

AU - De Benedetti, Fabrizio

AU - Alonzi, Tonino

AU - Moretta, Antonia

AU - Lazzaro, Domenico

AU - Costa, Patrizia

AU - Poli, Valeria

AU - Martini, Alberto

AU - Ciliberto, Gennaro

AU - Fattori, Elena

PY - 1997/2/15

Y1 - 1997/2/15

N2 - Stunted growth is a major complication of chronic inflammation and recurrent infections in children. Systemic juvenile rheumatoid arthritis is a chronic inflammatory disorder characterized by markedly elevated circulating levels of IL-6 and stunted growth. In this study we found that NSE/hIL-6 transgenic mouse lines expressing high levels of circulating IL-6 since early after birth presented a reduced growth rate that led to mice 50- 70% the size of nontransgenic littermates. Administration of a monoclonal antibody to the murine IL-6 receptor partially reverted the growth defect. In NSE/hIL-6 transgenic mice, circulating IGF-I levels were significantly lower than those of nontransgenic littermates; on the contrary, the distribution of growth hormone pituitary cells, as well as circulating growth hormone levels, were normal. Treatment of nontransgenic mice of the same strain with IL-6 resulted in a significant decrease in IGF-I levels. Moreover, in patients with systemic juvenile rheumatoid arthritis, circulating IL-6 levels were negatively correlated with IGF-I levels. Our findings suggest that IL-6-mediated decrease in IGF-I production represents a major mechanism by which chronic inflammation affects growth.

AB - Stunted growth is a major complication of chronic inflammation and recurrent infections in children. Systemic juvenile rheumatoid arthritis is a chronic inflammatory disorder characterized by markedly elevated circulating levels of IL-6 and stunted growth. In this study we found that NSE/hIL-6 transgenic mouse lines expressing high levels of circulating IL-6 since early after birth presented a reduced growth rate that led to mice 50- 70% the size of nontransgenic littermates. Administration of a monoclonal antibody to the murine IL-6 receptor partially reverted the growth defect. In NSE/hIL-6 transgenic mice, circulating IGF-I levels were significantly lower than those of nontransgenic littermates; on the contrary, the distribution of growth hormone pituitary cells, as well as circulating growth hormone levels, were normal. Treatment of nontransgenic mice of the same strain with IL-6 resulted in a significant decrease in IGF-I levels. Moreover, in patients with systemic juvenile rheumatoid arthritis, circulating IL-6 levels were negatively correlated with IGF-I levels. Our findings suggest that IL-6-mediated decrease in IGF-I production represents a major mechanism by which chronic inflammation affects growth.

KW - growth disorders

KW - insulin-like growth factor-I

KW - interleukin 6

KW - juvenile rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=0031025204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031025204&partnerID=8YFLogxK

M3 - Article

C2 - 9045866

AN - SCOPUS:0031025204

VL - 99

SP - 643

EP - 650

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 4

ER -